- Home
- BANF vs DYN Comparison
BANF vs DYN Comparison
Compare BANF & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANF | DYN |
|---|---|---|
| Founded | 1984 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BANF | DYN |
|---|---|---|
| Price | $115.82 | $18.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | ★ $129.50 | $39.94 |
| AVG Volume (30 Days) | 118.6K | ★ 2.1M |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ 10.40 | N/A |
| EPS | ★ 7.11 | N/A |
| Revenue | ★ $684,958,000.00 | N/A |
| Revenue This Year | $5.19 | N/A |
| Revenue Next Year | $3.34 | N/A |
| P/E Ratio | $15.89 | ★ N/A |
| Revenue Growth | ★ 10.04 | N/A |
| 52 Week Low | $97.02 | $6.36 |
| 52 Week High | $138.77 | $25.00 |
Technical Indicators
Market Signals| Indicator | BANF | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 62.75 | 49.73 |
| Support Level | $107.94 | $17.11 |
| Resistance Level | $110.07 | $19.39 |
| Average True Range (ATR) | 3.25 | 0.93 |
| MACD | 0.48 | 0.20 |
| Stochastic Oscillator | 96.56 | 66.37 |
Price Performance
Historical ComparisonAbout BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.